Form D · Pharmaceuticals
LifeCyte Innovations, Inc.
Greensboro, GA · CIK 0002150601
Offering snapshot reported Aug 20, 2026 · SEC filing
- Reported sold
- $1M Offering amount: $5M
- Investors reported
- 3 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Aug 12, 2026 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Aug 20, 2026 | Initial | $1,000,000 | No comparison | 3 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-594895
Source: Form D, filed Aug 20, 2026. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Kenneth Brown | Director, Executive |
| Michael Moorhead | Director, Executive |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
1221 Acorn Knob
Greensboro, GA, 30642
Greensboro, GA, 30642